Maternal and Pregnancy Outcomes in Women Initiating and Declining PrEP in Pregnancy: IMPAACT 2009
Background: FTC-TDF-based PrEP is recommended for pregnant people in settings of high HIV transmission. However, few have evaluated uptake, maternal safety, and pregnancy outcomes in the context of a clinical trial. Methods: The PrEP Comparison Component of IMPAACT 2009 enrolled pregnant participants aged 16-24 years at